Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The role of leg length discrepancy in low back pain
ISRCTN ISRCTN11898558
ClinicalTrials.gov identifier
Public title The role of leg length discrepancy in low back pain
Scientific title The efficacy of correction of leg length discrepancy on low back pain among meat industry workers
Acronym N/A
Serial number at source N/A
Study hypothesis Leg length discrepancy may be related to low back pain in occupations with prolonged walking and/or standing.
Lay summary
Ethics approval The Ethics Committee of South Ostrobothnia Central Hospital approved on 20th December 2006
Study design Randomised controlled trial
Countries of recruitment Finland
Disease/condition/study domain Low back pain
Participants - inclusion criteria 1. Any current low back pain [at least one on a 10-cm Visual Analog Scale (VAS)] and leg length discrepancy of at least 5 mm (measured with a laser-based method)
2. Workers with prolonged occupational standing and/or walking within meat industry (carvers and packers)
3. Exposure to occupational standing and/or walking of at least 10 years
4. Age 35 years or more
Participants - exclusion criteria 1. Any spinal red flags
2. Nerve root entrapment
3. Any previous leg fractures behind leg length discrepancy
Anticipated start date 05/02/2009
Anticipated end date 05/02/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants All workers fullfilling inclusion criteria within one meat factory in South Ostrobothnia. 20 participants in the intervention group and 22 participants in the control group.
Interventions Ultrasound is used to measure both legs of the participants and the leg length discrepancy (LLD) 5mm or more. We also ask, if the participants have low back pain (LBP) scale 1-10. Then we randomise them in two groups.

In the intervention group the participants are given soles which correct 70% of LLD. In the control group the participants are given soles without correction. We ask questions(Oswestry, Roland -Morris, RAND, pain scales) at the beginning of the study and after 3, 6 and 12 months
Primary outcome measure(s) Intensity of low back pain (10 cm-VAS), measured at the beginning of the study and after 3, 6 and 12 months
Secondary outcome measure(s) 1. Oswestry Disability
2. Roland-Morris Disability
3. RAND-36 Quality of Life
Measured at at the beginning of the study and after 3, 6 and 12 months
Sources of funding South Ostrobothnia Central Hospital (EVO) (Finland)
Trial website
Publications
Contact name Dr  Satu  Rannisto
  Address Hämeenpuisto 8B 15
  City/town Tampere
  Zip/Postcode 33210
  Country Finland
  Email satu.rannisto@sarastus.fi
Sponsor South Ostrobothnia Central Hospital (Finland)
  Address Huhtalantie 53,
  City/town Seinäjoki
  Zip/Postcode 60220
  Country Finland
  Email hannu.puolijoki@epshp.fi
  Sponsor website: http://www.epshp.fi/
Date applied 11/02/2011
Last edited 03/03/2011
Date ISRCTN assigned 03/03/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central